Takeda Pharmaceutical Company Limited Stock
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,359.00 JPY | +1.61% |
|
+5.35% | +10.84% |
| 07-02 | Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading | MT |
| 07-02 | Takeda, Insilico Sign AI-Driven Drug Discovery Pact | MT |
| Market Cap | 8,467B 52.5B 45.89B 42.17B 39.31B 74.56B 4,998B 75.69B 506B 197B 2,457B 197B 193B | P/E 2027 * |
43.6x | P/E 2028 * | 27.9x |
|---|---|---|---|---|---|
| Enterprise Value | 12,352B 76.59B 66.95B 61.53B 57.35B 109B 7,292B 110B 739B 287B 3,585B 287B 281B | EV / Sales 2027 * |
2.67x | EV / Sales 2028 * | 2.6x |
| Free-Float |
99.25% | Yield 2027 * |
3.81% | Yield 2028 * | 3.89% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +1.61% | ||
| 1 week | +5.35% | ||
| Current month | +3.96% | ||
| 1 month | +10.49% | ||
| 3 months | -7.64% | ||
| 6 months | +10.84% | ||
| Current year | +10.84% |
| 1 week | 5,100 |  | 5,515 |
| 1 month | 4,896 | | 5,515 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 24/06/2026 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-27 | Free | Chief Technology Officer | 212,470 | 0.0134% | ||
| 04-27 | Free | Chief Financial Officer | 15,614 | 0.0010% | ||
| 04-27 | Free | Chief Executive Officer | 323,248 | 0.0203% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.61% | +5.35% | +20.70% | +18.61% | 52.5B | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +31.35% | +24.29% | 338B | |
| -0.56% | +0.96% | +39.86% | +36.64% | 299B | |
| -0.08% | +1.30% | +30.37% | +44.02% | 291B | |
| -1.54% | +2.81% | -27.56% | -39.45% | 222B | |
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| Average | +2.05% | +4.66% | +29.97% | +53.90% | 374.49B | |
| Weighted average by Cap. | +2.24% | +5.53% | +41.48% | +82.10% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,630B 28.71B 25.1B 23.07B 21.5B 40.78B 2,734B 41.4B 277B 108B 1,344B 108B 105B | 4,701B 29.15B 25.48B 23.42B 21.83B 41.4B 2,775B 42.03B 281B 109B 1,364B 109B 107B |
| Net income | 184B 1.14B 997M 916M 854M 1.62B 109B 1.64B 11B 4.28B 53.37B 4.28B 4.19B | 309B 1.92B 1.68B 1.54B 1.44B 2.72B 183B 2.77B 18.5B 7.19B 89.76B 7.2B 7.04B |
| Net Debt | 3,886B 24.09B 21.06B 19.36B 18.04B 34.22B 2,294B 34.74B 232B 90.33B 1,128B 90.43B 88.49B | 3,750B 23.25B 20.33B 18.68B 17.41B 33.03B 2,214B 33.53B 224B 87.19B 1,088B 87.29B 85.41B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | ¥5,359.00 | +1.61% | 4,074,200 |
| 02/07/26 | ¥5,274.00 | +2.41% | 3,538,100 |
| 01/07/26 | ¥5,150.00 | -0.10% | 4,177,200 |
| 30/06/26 | ¥5,155.00 | -0.41% | 4,329,100 |
| 29/06/26 | ¥5,176.00 | +1.75% | 7,388,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
